Houston Methodist and Univ. of St. Thomas join to offer master’s degree in biomedical entrepreneurship

The University of St. Thomas Cameron School of Business and the Houston Methodist Research Institute are now offering a jointly administered Master in Clinical Translational Management degree to bridge the gap between science and business. Currently, there are only two similar programs in the U.S., one offered by the University of California San Francisco, the other by Johns Hopkins University.

By linking entrepreneurship and business development directly to advances in basic research and clinical practice, proponents of the program say it can help trainees learn to expedite the translation of research discoveries from bench to bedside, reducing the time needed to bring effective therapies to patients.

The Clinical Translational Management program will require completion of a minimum of 36 credits, including the successful completion of a Capstone project and participation in a seminar. The program is designed to fit the needs of both researchers and healthcare professionals interested in the business side of medical technology, or entrepreneurs looking to gain insights into the biomedical sector. The application for the program is now live for the first class of trainees starting in spring 2015. For more information, visit https://www.stthom.edu/MCTM.

The Houston Methodist Research Institute is pleased to announce the Abramson-Finger Scholars Fund to support students enrolled in the program. The scholarship fund was made possible by Rolaine and Morrie Abramson and by Elaine and Marvy Finger.